LYTIR

Company · OKYO

OKYO Pharma Limited

Name as listed on its exchange; filed with the SEC as OKYO Pharma Ltd.

Nasdaq's symbol directory lists OKYO on Nasdaq as “OKYO Pharma Limited - Ordinary Shares”.

In the 12 months to Nov 8, 2026: insiders bought on 7 occasions ($136K).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Gabriele M. Cerrone bought on 2 days latest Jul 21, 2026 bought $68K
  2. Flavio Mantelli, CHIEF MEDICAL OFFICER bought on 1 day latest Jul 21, 2026 bought $28K
  3. Robert John Dempsey, CHIEF EXECUTIVE OFFICER bought on 1 day latest Jul 22, 2026 bought $23K
  4. John P. Brancaccio bought on 1 day latest Jul 21, 2026 bought $7K
  5. Patil Rajkumar V., Chief Scientific Officer bought on 1 day latest Jul 27, 2026 bought $5K
  6. Gary S. Jacob, CHIEF DEVELOPMENT OFFICER bought on 1 day latest Jul 21, 2026 bought $5K
Every trade (7)
  1. BUYPatil Rajkumar V., Chief Scientific Officer bought Jul 27, 2026 3,363 shares filing $5K
  2. BUYRobert John Dempsey, CHIEF EXECUTIVE OFFICER bought Jul 22, 2026 15,000 shares filing $23K
  3. BUYGabriele M. Cerrone bought Jul 21, 2026 22,500 shares filing $33K
  4. BUYFlavio Mantelli, CHIEF MEDICAL OFFICER bought Jul 21, 2026 20,000 shares filing $28K
  5. BUYJohn P. Brancaccio bought Jul 21, 2026 5,000 shares filing $7K
  6. BUYGary S. Jacob, CHIEF DEVELOPMENT OFFICER bought Jul 21, 2026 3,500 shares filing $5K
  7. BUYGabriele M. Cerrone bought Jul 20, 2026 25,000 shares filing $35K

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.